Drug Type Radiolabeled antibody, Therapeutic radiopharmaceuticals |
Synonyms Anti-CTA monoclonal antibodies, HumaRADHN, HumaRADOV + [2] |
Target- |
Action- |
Mechanism Ionising radiation emitters |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Head and Neck Neoplasms | Phase 2 | - | - | |
Head and Neck Neoplasms | Phase 2 | - | - | |
Head and Neck Neoplasms | Phase 2 | - | - |